AstraZeneca PLC - Net Interest Income

AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Net-Interest-Income" stands at -1.35 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value at least since 06/30/2019, the period currently displayed.

AstraZeneca PLC's third quarter result of -0.349 Billion USD for the item "Net Interest Income" represents an increase of 5.93 percent compared to it's second quarter result.

Also, AstraZeneca PLC's third quarter result of -0.349 Billion USD for the item "Net Interest Income" represents a decrease of -27.37 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), AstraZeneca PLC's third quarter result of -1.35 Billion USD for the item "Net Interest Income" represents a decrease of -5.88 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -0.088 Billion United States Dollars compared to the value the year prior.
The 1 year change is -0.088 Billion United States Dollars.
The 3 year change is -0.079 Billion United States Dollars.
The 5 year change is -0.156 Billion United States Dollars.

The Serie's long term average value is -1.19 Billion United States Dollars. It's latest available value, on 09/30/2025, is -0.164 Billion United States Dollars lower, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is +0.0 Billion.
The Serie's change in United States Dollars from it's maximum value, on 03/31/2019, to it's latest available value, on 09/30/2025, is -1.04 Billion.